Peptomyc's Series A Round

Peptomyc raised a round of funding on September 06, 2017.

Peptomyc is a company focused on the development of a new generation of cell penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment.…

Articles about Peptomyc's Series A Round: